68
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

MTR-G is a high-risk allele for lower-extremity arteriosclerotic occlusion

, , , , &
Pages 1132-1136 | Received 21 Apr 2020, Accepted 08 Dec 2020, Published online: 30 Dec 2020

References

  • Hodis HN, Mack WJ, Dustin L, et al. High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial. Stroke. 2009;40(3):730–736.
  • Laraqui A, Allami A, Carrié A, et al. Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease. Acta Cardiol. 2006;61(1):51–61.
  • Hsu FC, Sides EG, Mychaleckyj JC, et al. Transcobalamin 2 variant associated with poststroke homocysteine modifies recurrent stroke risk. Neurology. 2011;77(16):1543–1550.
  • Vidal-Cardenas SL, Greider CW. Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase. Nucleic Acids Res. 2010;38(1):60–71.
  • Yamaji T, Iwasaki M, Sasazuki S, et al. Methionine synthase A2756G polymorphism interacts with alcohol and folate intake to influence the risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2009;18(1):267–274.
  • Chen J, Stampfer MJ, Ma J, et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis. 2001;154(3):667–672.
  • van Dijk SC, Smulders YM, Enneman AW, et al. Homocysteine level is associated with aortic stiffness in elderly: cross-sectional results from the B-PROOF study. J Hypertens. 2013;31(5):952–959.
  • Li L, Wang ZJ, Liu YC. Research progress on homocysteine and peripheral vascular occlusive disease. Shandong Med J. 2009; 49:356–357.
  • Zhao J, Chen H, Liu N, et al. Role of hyperhomocysteinemia and hyperuricemia in pathogenesis of atherosclerosis. J Stroke Cerebrovasc Dis. 2017;26(12):2695–2699.
  • Blundell G, Jones BG, Rose FA, et al. Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis. 1996;122(2):163–172.
  • Cheng GH, Zhu YQ, Zhang CH, et al. Homocysteine/cysteine induced novel cDNAs in vascular smooth muscle cells. Chin J Biochem Mol Bio. 1998; 14:8–14.
  • Xiao Y, Xia J, Cheng J, et al. Inhibition of S-adenosylhomocysteine hydrolase induces endothelial dysfunction via epigenetic regulation of p66shc-mediated oxidative stress pathway. Circulation. 2019;139(19):2260–2277.
  • Huang C, Zhang L, Wang Z, et al. Endothelial progenitor cells are associated with plasma homocysteine in coronary artery disease. Acta Cardiol. 2011;66(6):773–777.
  • Zanin RF, Campesato LF, Braganhol E, et al. Homocysteine decreases extracellular nucleotide hydrolysis in rat platelets. Thromb Res. 2010;125(3):e87–e92.
  • Okada E, Oida K, Tada H, et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care. 1999;22(3):484–490.
  • Koch HG, Goebeler M, Marquardt T, et al. The redox status of aminothiols as a clue to homocysteine-induced vascular damage? Eur J Pediatr. 1998;157(Suppl 2):S102–S106.
  • Brown CA, McKinney KQ, Kaufman JS, et al. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease. J Cardiovasc Risk. 2000;7(3):197–200.
  • Ashavaid TF, Shalia KK, Kondkar AA, et al. Gene polymorphism and coronary risk factors in Indian population. Clin Chem Lab Med. 2002;40(10):975–985.
  • Lu M, Wang F, Qiu J. Methionine synthase A2756G polymorphism and breast cancer risk: a meta-analysis involving 18,953 subjects. Breast Cancer Res Treat. 2010;123(1):213–217.
  • Osunkalu VO, Taiwo IA, Makwe CC, et al. Methylene tetrahydrofolate reductase and methionine synthase gene polymorphisms as genetic determinants of pre-eclampsia. Pregnancy Hypertens. 2020;20:7–13.
  • Zhang BZ, Dai BQ, Zhang XL, et al. Associations of maternal methionine synthase A2756G and methionine synthase reductase A66G polymorphisms with neural tube defects of the offspring: a meta-analysis. J Shandong Univ (Health Sci). 2012;50:125–132.
  • Fillon-Emery N, Chango A, Mircher C, et al. Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms. Am J Clin Nutr. 2004;80(6):1551–1557.
  • Harmon DL, Shields DC, Woodside JV, et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol. 1999;17(4):298–309.
  • Klerk M, Lievers KJ, Kluijtmans LA, et al. The 2756A > G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study. Thromb Res. 2003;110(2-3):87–91.
  • Kluijtmans LA, Young IS, Boreham CA, et al. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood. 2003;101(7):2483–2488.
  • Webb PM, Ibiebele TI, Hughes MC, et al. Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer. Eur J Clin Nutr. 2011;65(10):1133–1140.
  • Ng X, Boyd L, Dufficy L, et al. Folate nutritional genetics and risk for hypertension in an elderly population sample. J Nutrigenet Nutrigenomics. 2009;2(1):1–8.
  • Papoutsakis C, Yiannakouris N, Manios Y, et al. The effect of MTHFR(C677T) genotype on plasma homocysteine concentrations in healthy children is influenced by gender. Eur J Clin Nutr. 2006;60(2):155–162.
  • Zhong DM, Huang XQ. Detection of A2756G mutation frequency of methionine synthase gene in elderly patients with ischemic stroke in Guangxi Zhuang Nationality. Chin J Diff Compl Cas. 2012; 11:454–455.
  • Galván-Portillo MV, Cantoral A, Oñate-Ocaña LF, et al. Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers. Eur J Nutr. 2009;48(5):269–276.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.